產(chǎn)品詳情
簡(jiǎn)單介紹:
AtomoxetineHCl
詳情介紹:
Purpose | Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine. This chemical is manufactured and marketed under the brand name Strattera, by Eli Lilly and Company and as a generic Attentin by Torrent Pharmaceuticals. There is currently no generic available within the United States due to patent restrictions. |
Characteristics |
Tradename: STRATTERA Source of Compound: synthetic, LY-139603 Target: Dopamine uptake inhibitor,Noradrenaline uptake inhibitor,Serotonin uptake inhibitor Receptor: Sodium-dependent dopamine transporter,Sodium-dependent noradrenaline transporter,Sodium-dependent serotonin transporter Status: USAN, INN, BAN |
Purification | All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality. |
Purity | 97?% |
Formula | C17H22ClNO |
Solubility | Water:27.8 mg/mL |
Molecular Weight | 291.82 g/mol |
CAS-No | 82248-59-7 |
Application Notes | Optimal working dilution should be determined by the investigator. |
Restrictions | For Research Use only |
Format | Solid |
Storage | -20 °C |
Storage Comment |
For the majority of compounds, they could be dissolved in DMSO or other organic solvent. Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience. Several freeze/thaw cycles should not damage the activity of our small molecule products. However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours. |
Expiry Date | 24 months |